RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @alongi_filippo: long-term outcomes of STOMP and ORIOLE demonstrate sustained benefit to MDT over observation in omCSPC.Genomic alterati…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @PBlanchardMD: Very important update of the pooled analysis of STOMP and ORIOLE for the #radonc #pcsm community. cc @GETUG_Unicancer
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @Sushilberiwal: MDT benefit in prostate OM with and without high risk mutation
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @williamyshi: This is really excellent work! Very cool to see that the high risk-mutational signature identified in ORIOLE stratifies lo…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Correct link: https://t.co/7bEFItCHOv
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
MDT benefit in prostate OM with and without high risk mutation
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
This is really excellent work! Very cool to see that the high risk-mutational signature identified in ORIOLE stratifies long term outcomes of the pooled cohort.
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @alongi_filippo: long-term outcomes of STOMP and ORIOLE demonstrate sustained benefit to MDT over observation in omCSPC.Genomic alterati…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @UMarylandRadOnc: Long-Term Outcomes and Genetic Predictors of Response to MDT from STOMP and ORIOLE Trials. https://t.co/5F3gFQGzGf. Th…
RT @alongi_filippo: long-term outcomes of STOMP and ORIOLE demonstrate sustained benefit to MDT over observation in omCSPC.Genomic alterati…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials DOI: https://t.co/zQarrWowpW
Excellent work re: MDT in oligorecurrent prostate cancer.
RT @piet_ost: Correct link: https://t.co/7bEFItCHOv
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: 🧵tweetorial from @piet_ost here;
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @alongi_filippo: long-term outcomes of STOMP and ORIOLE demonstrate sustained benefit to MDT over observation in omCSPC.Genomic alterati…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @alongi_filippo: long-term outcomes of STOMP and ORIOLE demonstrate sustained benefit to MDT over observation in omCSPC.Genomic alterati…
long-term outcomes of STOMP and ORIOLE demonstrate sustained benefit to MDT over observation in omCSPC.Genomic alterations have prognostic value in this patients, suggesting that biomarkers should be evaluated in future studies to optimize patient selectio
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @UMarylandRadOnc: Long-Term Outcomes and Genetic Predictors of Response to MDT from STOMP and ORIOLE Trials. https://t.co/5F3gFQGzGf. Th…
critical data. hugely patient centered intervention avoiding systemic effects. better selection among HR gene mutations. #precisionmedicine #ProstateCancer do we need more data against ADT+NHT
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Correct link: https://t.co/7bEFItCHOv
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @UMarylandRadOnc: Long-Term Outcomes and Genetic Predictors of Response to MDT from STOMP and ORIOLE Trials. https://t.co/5F3gFQGzGf. Th…
RT @UMarylandRadOnc: Long-Term Outcomes and Genetic Predictors of Response to MDT from STOMP and ORIOLE Trials. https://t.co/5F3gFQGzGf. Th…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
RT @UMarylandRadOnc: Long-Term Outcomes and Genetic Predictors of Response to MDT from STOMP and ORIOLE Trials. https://t.co/5F3gFQGzGf. Th…
RT @piet_ost: Finally here: 1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE). 2/Analysis of the im…
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…
Long-Term Outcomes and Genetic Predictors of Response to MDT from STOMP and ORIOLE Trials. https://t.co/5F3gFQGzGf. Thanks to patients, collaborators and funders. @JCO_ASCO #JCO #radonc @piet_ost https://t.co/ETNdKpcTxI
RT @_ShankarSiva: STOMP and ORIOLE long term outcomes. Metastasis-directed SABR in oligometastatic #prostatecancer ⬆️PFS from 5.9mo to 11.9…